Literature DB >> 35325224

Improving survival in neuro-oncology is a struggle; we cannot allow ourselves to also struggle with issues of diversity.

Annick Desjardins1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35325224      PMCID： PMC9340615          DOI： 10.1093/neuonc/noac069

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  5 in total

Review 1.  Barriers to accrual and enrollment in brain tumor trials.

Authors:  Eudocia Q Lee; Ugonma N Chukwueke; Shawn L Hervey-Jumper; John F de Groot; Jose Pablo Leone; Terri S Armstrong; Susan M Chang; David Arons; Kathy Oliver; Kay Verble; Al Musella; Nicole Willmarth; Brian M Alexander; Amanda Bates; Lisa Doherty; Evanthia Galanis; Sarah Gaffey; Thomas Halkin; Bret E Friday; Maryam Fouladi; Nancy U Lin; David Macdonald; Minesh P Mehta; Marta Penas-Prado; Michael A Vogelbaum; Solmaz Sahebjam; David Sandak; Martin van den Bent; Michael Weller; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2019-09-06       Impact factor: 12.300

Review 2.  Disparities and Inequities Among Patients with Central Nervous System Tumor.

Authors:  Ugonma N Chukwueke; Shawn Hervey-Jumper; Alyx Porter
Journal:  Hematol Oncol Clin North Am       Date:  2022-02       Impact factor: 3.722

3.  A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.

Authors:  Sheantel J Reihl; Nirav Patil; Ramin A Morshed; Mulki Mehari; Alexander Aabedi; Ugonma N Chukwueke; Alyx B Porter; Valy Fontil; Gino Cioffi; Kristin Waite; Carol Kruchko; Quinn Ostrom; Jill Barnholtz-Sloan; Shawn L Hervey-Jumper
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

4.  Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.

Authors:  Ryan Rhome; Rebecca Fisher; Adília Hormigo; Rahul R Parikh
Journal:  J Neurooncol       Date:  2016-03-12       Impact factor: 4.130

5.  SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology.

Authors:  Ugonma N Chukwueke; Elizabeth Vera; Alvina Acquaye; Shawn L Hervey-Jumper; Yazmin Odia; Laura J Klesse; Erin Dunbar; Akanksha Sharma; Ekokobe Fonkem; Alissa A Thomas; Tamra E Werbowetski-Ogilvie; Sandra Camelo-Piragua; Na Tosha N Gatson; Macarena I de la Fuente; Terri S Armstrong; Alyx B Porter; Sadhana Jackson
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.